{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:17:48Z","timestamp":1794514668867,"version":"4.9.1"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/01.mpa.0000240617.66215.d2","type":"journal-article","created":{"date-parts":[[2006,12,22]],"date-time":"2006-12-22T04:27:04Z","timestamp":1166761624000},"page":"15-20","source":"Crossref","is-referenced-by-count":54,"title":["Coagulation, Platelets, and Acute Pancreatitis"],"prefix":"10.1097","volume":"34","author":[{"given":"Anna","family":"Kakafika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Mimidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210212","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000085265","article-title":"Pathophysiology of acute pancreatitis.","volume":"5","author":"Bhatia","year":"2005","journal-title":"Pancreatology"},{"key":"R2-2-20210212","first-page":"225","article-title":"Inflammatory response in the initial phase of acute pancreatitis: relationship to the onset and severity of the disease.","volume":"87","author":"Dominguez-Munoz","year":"1995","journal-title":"Rev Esp Enferm Dig"},{"key":"R3-2-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000070078","article-title":"Natural history of organ failure in acute pancreatitis.","volume":"3","author":"McKay","year":"2003","journal-title":"Pancreatology"},{"key":"R4-2-20210212","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00042737-199702000-00001","article-title":"Acute pancreatitis: overview.","volume":"9","author":"Imrie","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R5-2-20210212","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1568010023344517","article-title":"Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome.","volume":"1","author":"Bhatia","year":"2002","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"R6-2-20210212","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02798921","article-title":"Fatal pancreatitis, a consequence of excessive leukocyte stimulation?","volume":"3","author":"Rinderknecht","year":"1988","journal-title":"Int J Pancreatol"},{"key":"R7-2-20210212","first-page":"428","article-title":"Neutral endopeptidase (NEP) plays an anti-inflammatory role in acute pancreatitis and pancreatitis-associated lung injury.","volume":"15","author":"Bhatia","year":"1997","journal-title":"Pancreas"},{"key":"R8-2-20210212","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000066090","article-title":"Acute experimental pancreatitis and NF-kappaB\/Rel activation.","volume":"2","author":"Algul","year":"2002","journal-title":"Pancreatology"},{"issue":"suppl 1","key":"R9-2-20210212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.shk.0000191413.94461.b0","article-title":"Acute pancreatitis: models, markers, and mediators.","volume":"24","author":"Granger","year":"2005","journal-title":"Shock"},{"key":"R10-2-20210212","first-page":"502","article-title":"The relationship of coagulation factors to clinical complications of acute pancreatitis.","volume":"81","author":"Ranson","year":"1977","journal-title":"Surgery"},{"key":"R11-2-20210212","first-page":"115","article-title":"Acute pancreatitis: a multisystem disease.","volume":"1","author":"Agarwal","year":"1993","journal-title":"Gastroenterologist"},{"key":"R12-2-20210212","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02788446","article-title":"Ultrastructure of human acute pancreatitis.","volume":"1","author":"Bockman","year":"1986","journal-title":"Int J Pancreatol"},{"key":"R13-2-20210212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1661521","article-title":"Platelet function in experimentally induced pancreatitis in the dog.","volume":"55","author":"Jacobs","year":"1986","journal-title":"Thromb Haemost"},{"key":"R14-2-20210212","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0049-3848(89)90106-0","article-title":"Does acute experimental pancreatitis affect blood platelet function?","volume":"1","author":"Lukaszyk","year":"1989","journal-title":"Thromb Res"},{"key":"R15-2-20210212","first-page":"805","article-title":"Biochemical and coagulation changes in a canine model of acute necrotizing pancreatitis.","volume":"42","author":"Feldman","year":"1981","journal-title":"Am J Vet Res"},{"key":"R16-2-20210212","first-page":"1746","article-title":"Evaluation of hemostatic changes and blood antioxidant capacity in acute and chronic pancreatitis.","volume":"48","author":"Kerekes","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"R17-2-20210212","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00006676-199003000-00011","article-title":"Injection of microspheres into pancreatic arteries causes acute hemorrhagic pancreatitis in the rat: a new animal model.","volume":"5","author":"Redha","year":"1990","journal-title":"Pancreas"},{"key":"R18-2-20210212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0049-3848(86)90227-6","article-title":"Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis.","volume":"41","author":"Lasson","year":"1986","journal-title":"Thromb Res"},{"key":"R19-2-20210212","first-page":"83","article-title":"Studies on pathological plasma proteolysis in patients with acute pancreatitis. A preliminary report.","volume":"509","author":"Aasen","year":"1982","journal-title":"Acta Chir Scand Suppl"},{"key":"R20-2-20210212","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00006676-200408000-00010","article-title":"Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis.","volume":"29","author":"Radenkovic","year":"2004","journal-title":"Pancreas"},{"key":"R21-2-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006676-200303000-00003","article-title":"Coagulative disorders in human acute pancreatitis: role for the D-dimer.","volume":"26","author":"Salomone","year":"2003","journal-title":"Pancreas"},{"key":"R22-2-20210212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000077024","article-title":"Alterations of platelet function, number and indexes during acute pancreatitis.","volume":"4","author":"Mimidis","year":"2004","journal-title":"Pancreatology"},{"key":"R23-2-20210212","first-page":"237","article-title":"Platelet aggregation, platelet serotonin and pancreatitis.","volume":"5","author":"Lechin","year":"2004","journal-title":"JOP"},{"key":"R24-2-20210212","first-page":"1063","article-title":"Serotonin, histamine and platelets in vascular disease with special reference to peripheral vascular disease.","volume":"25","author":"Barradas","year":"1992","journal-title":"Braz J Med Biol Res"},{"key":"R25-2-20210212","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0022-4804(84)90195-1","article-title":"Platelet activation by human pancreatic fluid.","volume":"37","author":"Prinz","year":"1984","journal-title":"J Surg Res"},{"key":"R26-2-20210212","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF01965409","article-title":"Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41468), a selective 5-HT2-receptor antagonist.","volume":"12","author":"De Clerck","year":"1982","journal-title":"Agents Actions"},{"key":"R27-2-20210212","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0038-1648163","article-title":"MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist.","volume":"65","author":"Hara","year":"1991","journal-title":"Thromb Haemost"},{"key":"R29-2-20210212","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0024-3205(92)90476-6","article-title":"Effects of the S2-serotonergic receptor antagonist, ketanserin, on cerulein-induced pancreatitis in the rat.","volume":"50","author":"Oguchi","year":"1992","journal-title":"Life Sci"},{"key":"R30-2-20210212","first-page":"1495","article-title":"Possible involvement of 5-HT2 receptor activation in aggravation of diet-induced acute pancreatitis in mice.","volume":"283","author":"Yoshino","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R31-2-20210212","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2005.08.033","article-title":"Effects of R-102444 and its active metabolite R-96544, selective 5-HT2A receptor antagonists, on experimental acute and chronic pancreatitis: additional evidence for possible involvement of 5-HT2A receptors in the development of experimental pancreatitis.","volume":"521","author":"Ogawa","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R32-2-20210212","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00000658-198408000-00008","article-title":"Role of serotonin in patients with acute respiratory failure.","volume":"200","author":"Huval","year":"1984","journal-title":"Ann Surg"},{"key":"R33-2-20210212","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/cc3966","article-title":"Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis.","volume":"10","author":"Lindstrom","year":"2006","journal-title":"Crit Care"},{"key":"R34-2-20210212","first-page":"132","article-title":"Assessment of platelet adhesiveness and aggregation in mild acute pancreatitis using the PFA-100 system.","volume":"5","author":"Mimidis","year":"2004","journal-title":"JOP"},{"key":"R35-2-20210212","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000018699","article-title":"Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis.","volume":"16","author":"Johnson","year":"1999","journal-title":"Dig Surg"},{"key":"R36-2-20210212","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bjs.1800820105","article-title":"Inflammatory mediators in acute pancreatitis.","volume":"82","author":"Formela","year":"1995","journal-title":"Br J Surg"},{"key":"R37-2-20210212","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00006676-199307000-00006","article-title":"Release of platelet-activating factor in acute experimental pancreatitis.","volume":"8","author":"Kald","year":"1993","journal-title":"Pancreas"},{"key":"R38-2-20210212","first-page":"415","article-title":"The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure.","volume":"172","author":"Anderson","year":"1991","journal-title":"Surg Gynecol Obstet"},{"key":"R39-2-20210212","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000077254","article-title":"Beneficial effects of recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis.","volume":"36","author":"Bedirli","year":"2004","journal-title":"Eur Surg Res"},{"key":"R40-2-20210212","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0016-5085(98)70096-4","article-title":"Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis.","volume":"115","author":"Hofbauer","year":"1998","journal-title":"Gastroenterology"},{"key":"R41-2-20210212","first-page":"151","article-title":"Structure-activity relationships for BB-823 and related PAF-antagonists.","volume":"10","author":"Whittaker","year":"1994","journal-title":"J Lipid Mediators Cell Signal"},{"key":"R42-2-20210212","first-page":"1239","article-title":"Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis.","volume":"84","author":"McKay","year":"1997","journal-title":"Br J Surg"},{"issue":"suppl","key":"R43-2-20210212","first-page":"A12","article-title":"Lexipafant, a platelet activating factor (PAF) antagonist reduces mortality in a randomized placebo controlled study in patients with severe acute pancreatitis.","volume":"40","author":"Toh","year":"1997","journal-title":"Gut"},{"key":"R44-2-20210212","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/gut.48.1.62","article-title":"Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.","volume":"48","author":"Johnson","year":"2001","journal-title":"Gut"},{"key":"R45-2-20210212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/11024150260102816","article-title":"Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials.","volume":"168","author":"Abu-Zidan","year":"2002","journal-title":"Eur J Surg"},{"key":"R46-2-20210212","first-page":"1570","article-title":"Pathomorphological changes in microcirculation of pancreas during experimental acute pancreatitis.","volume":"47","author":"Kaska","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"R47-2-20210212","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/bjs.4966","article-title":"Platelet function in acute experimental pancreatitis induced by ischaemia-reperfusion.","volume":"92","author":"Hackert","year":"2005","journal-title":"Br J Surg"},{"key":"R48-2-20210212","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00004836-200006000-00002","article-title":"Etiology and pathogenesis of acute pancreatitis: current concepts.","volume":"30","author":"Sakorafas","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"R49-2-20210212","first-page":"463","article-title":"Expression of platelet endothelial cell adhesion molecule-1 between pancreatic microcirculation and peripheral circulation in rats with acute edematous pancreatitis.","volume":"2","author":"Gao","year":"2003","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R50-2-20210212","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3748\/wjg.v11.i5.661","article-title":"Differences in platelet endothelial cell adhesion molecule-1 expression between peripheral circulation and pancreatic microcirculation in cerulein-induced acute edematous pancreatitis.","volume":"11","author":"Gao","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R51-2-20210212","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00006676-200304000-00002","article-title":"Further evidence for endothelin as an important mediator of pancreatic and intestinal ischemia in severe acute pancreatitis.","volume":"26","author":"Inoue","year":"2003","journal-title":"Pancreas"},{"key":"R52-2-20210212","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2613.2003.00359.x","article-title":"The endothelin-1 receptor antagonists ameliorate histology and ultrastructural alterations in the pancreas and decrease trypsinogen activation in severe taurocholate pancreatitis in rats.","volume":"84","author":"Andrzejewska","year":"2003","journal-title":"Int J Exp Pathol"},{"key":"R53-2-20210212","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/157016105774329453","article-title":"Endothelin-1 and human platelets.","volume":"3","author":"Jagroop","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"R54-2-20210212","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.3748\/wjg.v11.i21.3171","article-title":"Resveratrol: a medical drug for acute pancreatitis.","volume":"11","author":"Ma","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R55-2-20210212","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0049-3848(02)00273-6","article-title":"Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin.","volume":"15","author":"Olas","year":"2002","journal-title":"Thromb Res"},{"key":"R56-2-20210212","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0891-5849(02)01430-2","article-title":"Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia\/reperfusion, platelet-activating factor, or oxidants.","volume":"34","author":"Shigematsu","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"R57-2-20210212","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1161\/01.CIR.0000029925.18593.5C","article-title":"Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.","volume":"106","author":"Wallerath","year":"2002","journal-title":"Circulation"},{"key":"R58-2-20210212","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/jcp.35.11.1244","article-title":"Morphological study of the relation between accidental hypothermia and acute pancreatitis.","volume":"35","author":"Foulis","year":"1982","journal-title":"J Clin Pathol"},{"key":"R59-2-20210212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1042\/cs061028Pa","article-title":"Effect of cooling on prostaglandin mediated inhibition of platelet aggregation.","volume":"61","author":"Mikhailidis","year":"1981","journal-title":"Clin Sci"},{"key":"R60-2-20210212","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jcp.36.4.483","article-title":"Hypothermia and pancreatitis.","volume":"36","author":"Mikhailidis","year":"1983","journal-title":"J Clin Pathol"},{"key":"R61-2-20210212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/diab.32.3.217","article-title":"Simulating the diabetic environment modifies in vitro prostacyclin synthesis.","volume":"32","author":"Jeremy","year":"1983","journal-title":"Diabetes"},{"key":"R62-2-20210212","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/09537109609023571","article-title":"Plasma albumin and platelet function: relevance to atherogenesis and thrombosis.","volume":"7","author":"Mikhailidis","year":"1996","journal-title":"Platelets"},{"key":"R63-2-20210212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2007-995822","article-title":"Disseminated intravascular coagulation in patients with multiple organ failure of non-septic origin.","volume":"24","author":"Penner","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"R64-2-20210212","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<65::AID-AJH13>3.0.CO;2-0","article-title":"Disseminated intravascular coagulation: clinical and laboratory aspects.","volume":"59","author":"Carey","year":"1998","journal-title":"Am J Hematol"},{"key":"R65-2-20210212","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/BF02779186","article-title":"Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs.","volume":"25","author":"Satake","year":"1990","journal-title":"Gastroenterol Jpn"},{"key":"R66-2-20210212","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(02)12020-4","article-title":"Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation.","volume":"360","author":"Moberg","year":"2002","journal-title":"Lancet"},{"key":"R67-2-20210212","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2337\/diabetes.53.6.1407","article-title":"Human pancreatic duct cells exert tissue factor-dependent procoagulant activity.","volume":"53","author":"Beuneu","year":"2004","journal-title":"Diabetes"},{"key":"R68-2-20210212","first-page":"2128","article-title":"The concept of SIRS and severe acute pancreatitis.","volume":"62","author":"Hirota","year":"2004","journal-title":"Nippon Rinsho"},{"key":"R69-2-20210212","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nm841","article-title":"Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.","volume":"9","author":"Bogdanov","year":"2003","journal-title":"Nature Med"},{"issue":"suppl 1","key":"R70-2-20210212","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/j.seminhematol.2003.11.028","article-title":"Tissue factor as an evolutionary conserved cytokine receptor: implications for inflammation and signal transduction.","volume":"1","author":"Versteeg","year":"2004","journal-title":"Semin Hematol"},{"key":"R72-2-20210212","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2044.2004.03679.x","article-title":"Tissue factor and tissue factor pathway inhibitor.","volume":"59","author":"Price","year":"2004","journal-title":"Anaesthesia"},{"key":"R73-2-20210212","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0049-3848(03)00151-8","article-title":"Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients.","volume":"109","author":"Gando","year":"2003","journal-title":"Thromb Res"},{"key":"R74-2-20210212","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.3748\/wjg.v10.i17.2553","article-title":"Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats.","volume":"10","author":"Dobosz","year":"2004","journal-title":"World J Gastroenterol"},{"key":"R75-2-20210212","first-page":"303","article-title":"Heparin and nitric oxide treatment in experimental acute pancreatitis in rats.","volume":"8","author":"Dobosz","year":"1998","journal-title":"Forum (Genova)"},{"key":"R76-2-20210212","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0022-4804(87)90125-9","article-title":"111In-platelet and 125I-fibrinogen deposition in the lungs in experimental acute pancreatitis.","volume":"43","author":"Goulbourne","year":"1987","journal-title":"J Surg Res"},{"key":"R77-2-20210212","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0016-5107(04)00159-2","article-title":"Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.","volume":"59","author":"Rabenstein","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R78-2-20210212","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.surg.2003.08.001","article-title":"Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis.","volume":"135","author":"Hackert","year":"2004","journal-title":"Surgery"},{"key":"R79-2-20210212","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0016-5085(03)00384-6","article-title":"Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.","volume":"124","author":"Murray","year":"2003","journal-title":"Gastroenterology"},{"key":"R80-2-20210212","first-page":"107","article-title":"Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.","volume":"52","author":"Jaworek","year":"2001","journal-title":"J Physiol Pharmacol"},{"key":"R81-2-20210212","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/0016-5085(87)90258-7","article-title":"Vasoactive drugs, microvascular permeability, and hemorrhagic pancreatitis in cats.","volume":"93","author":"Harvey","year":"1987","journal-title":"Gastroenterology"},{"key":"R82-2-20210212","first-page":"309","article-title":"Salycylate-induced pancreatic injury in the cat: a preliminary study.","volume":"11","author":"Mentes","year":"2002","journal-title":"Rom J Gastroenterol"},{"key":"R83-2-20210212","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00134-004-2210-z","article-title":"Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.","volume":"30","author":"Dellinger","year":"2004","journal-title":"Intensive Care Med"},{"key":"R84-2-20210212","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"key":"R85-2-20210212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-0037-1612959","article-title":"Mechanism of resveratrol-mediated suppression of tissue factor gene expression.","volume":"87","author":"Pendurthi","year":"2002","journal-title":"Thromb Haemost"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006676-200701000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:17:53Z","timestamp":1786033073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006676-200701000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mpa.0000240617.66215.d2","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}